Santaris Pharma is building an international biopharmaceutical business for the 21st century, focused on the exciting new field of RNA medicines.

Our unique RNA Antagonist, based on the RNA analogue, Locked Nucleic Acid, has transformed the field of antisense drugs, making safe and effective gene silencing an achievable goal in human medicine.

The Company's pipeline of novel drugs in development is focused on improving patient out-come in cancer, metabolic disorders and viral diseases.